Mirum Pharmaceuticals, Inc.: accounts_receivable
| Value | {"amount": 60430000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-06-30) |
| Status | current |
| Entity | Mirum Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:53:34.758910+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/91abd09b-7e31-452e-9ce4-71f455367347
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001759425-24-000031Retrieved: 2026-08-19T17:53:34.758910+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001759425/accounts-receivable/2024-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/91abd09b-7e31-452e-9ce4-71f455367347
History
- no predecessors — first report